|
China's first domestically developed long-acting injectable AIDS drug will be available to the public in August, and is expected to benefit tens of thousands of people infected with HIV. 我国首款自主研发的长效注射用抗艾滋病新药将于8月上市，有望造福于数十万名艾滋感染者。 The drug, Albuvirtide, was recently approved by the State Drug Administration, according to a notice on the administration's website. 根据国家药品监督管理局网站发布的通知，新药“艾博卫泰”近日获批上市。 Developed by Nanjing-based Frontier Biotechnologies, the drug is said to be able to block the fusion of the virus and host cell membranes, interrupting the HIV life cycle in its earliest stage. 该药由前沿生物药业（南京）股份有限公司研发，据称可以通过抑制病毒包膜与人体细胞膜的融合，从而在感染初始环节阻断病毒复制周期。 | 
